Adakveo

Crizanlizumab-Tmca

6.4 Moderate risk

Adakveo & Pain

21.9%

of users reported Pain

60.5%

also reported Hospitalization

55.6%

are women

Most common medical consequences

Hospitalization

60.5%

Severe reaction

38.2%

Disability

1.3%

Have you experienced any negative side effects from this medication?

Adakveo: general information

Most common side effects (25)

Most commonly affected ages

10 - 19 years

25.8%

20 - 29 years

35.8%

30 - 39 years

24.1%

40 - 49 years

14.3%